GlaxoSmithKline Pharmaceuticals Receives ₹222.23 Crore Tax Refund For FY 2022-23, Reports 37.8% YoY Net Profit Increase In Q1 2024

GlaxoSmithKline Pharmaceuticals Receives ₹222.23 Crore Tax Refund For FY 2022-23, Reports 37.8% YoY Net Profit Increase In Q1 2024

Global pharma giant GlaxoSmithKline Pharmaceuticals Ltd received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order issued by the Income Tax Department on Tuesday.

FPJ News ServiceUpdated: Wednesday, September 04, 2024, 01:15 AM IST
article-image
GlaxoSmithKline gets tax refund of ₹222.23 crore | Representational Image

Global pharma giant GlaxoSmithKline Pharmaceuticals Ltd received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order issued by the Income Tax Department on Tuesday.

Global healthcare major informed in regulatory filings of an Income Tax Order for Assessment Year 2022-23 issuing income tax refund of Rs 222.23 cr including interest.

GlaxoSmithKline Pharmaceuticals declared a 37.8% year-on-year (YoY) increase in net profit to Rs.182.3 crore in the first quarter ended June 30, 2024. GlaxoSmithKline’s net profit in the same quarter was Rs.132.3 crore while revenue rose by 7% to Rs.814.7 crore from Rs.761.7 crore in the same period last year

RECENT STORIES

Weekly Market Review: Top Stocks That Were In Focus For The Week Ended 4th Jul’25

Weekly Market Review: Top Stocks That Were In Focus For The Week Ended 4th Jul’25

Mainboard IPOs Made A Strong Comeback In May, Signal Renewed Strength In Indian Markets

Mainboard IPOs Made A Strong Comeback In May, Signal Renewed Strength In Indian Markets

CCI Probe Indicts Ultratech In ONGC Tender Cartelisation Case

CCI Probe Indicts Ultratech In ONGC Tender Cartelisation Case

RBI Withdraws ₹1 Lakh Crore Via 7-Day VRRR Auction To Curb Surplus Banking Liquidity Levels

RBI Withdraws ₹1 Lakh Crore Via 7-Day VRRR Auction To Curb Surplus Banking Liquidity Levels

BSE Schedules Mock Trading For Equity Segment, Members Invited To Test Systems On July 5

BSE Schedules Mock Trading For Equity Segment, Members Invited To Test Systems On July 5